3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Head & Neck
1
Conditions
Lung Neoplasms
65
Carcinoma, Non-Small-Cell Lung
46
Neoplasms
9
Breast Neoplasms
9
Melanoma
7
Head and Neck Neoplasms
7
Ovarian Neoplasms
6
Colorectal Neoplasms
5
Small Cell Lung Carcinoma
4
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Pancreatic Neoplasms
3
Neoplastic Cells, Circulating
3
Neoplasm Metastasis
3
Mesothelioma
3
Kidney Neoplasms
3
Esophageal Neoplasms
3
Stomach Neoplasms
2
Sarcoma
2
Plaque, Atherosclerotic
2
Liver Neoplasms
2
Endometrial Neoplasms
2
Disease
2
Colonic Neoplasms
2
Bronchitis, Chronic
2
Adenocarcinoma
2
Vulvar Neoplasms
1
Uterine Neoplasms
1
Urologic Neoplasms
1
Thyroid Neoplasms
1
Interventions
Cisplatin
57
Pemetrexed
46
pembrolizumab
18
Nivolumab
15
Carboplatin
15
Gemcitabine
14
Cyclophosphamide
13
Radiotherapy
10
Drug Therapy
9
atezolizumab
8
Platinum
7
Ipilimumab
7
Doxorubicin
7
durvalumab
6
1,2-diaminocyclohexaneplatinum II citrate
6
tremelimumab
5
sodium thiosulfate
5
Vinorelbine
5
Radiotherapy, Intensity-Modulated
5
Interleukin-2
5
Chemotherapy, Adjuvant
5
Cerebral Decortication
5
sargramostim
4
fludarabine
4
defactinib
4
aldesleukin
4
tumor necrosis factor-alpha, CNGRC fusion protein, human
3
cediranib
3
Photochemotherapy
3
Neoadjuvant Therapy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Mesothelioma, Malignant
×
Blood Specimen Collection
×
Thoracic
×
Clear all
NCT07550049
2026-04-24
COMETH
University of Kansas Medical Center
Not yet recruiting
110 enrolled